ABCG2 and non-small cell lung carcinoma: Moreover, inhibition of miR-128-3p decreased the IC50 values for cisplatin, gemcitabine and paclitaxel, increased cellular drug uptake, reduced expression of drug transporters CTR2 and ABCG2, and promoted cellular apoptosis induced by these chemotherapeutic drugs in NSCLC cells (Supplementary Fig.4h–l).